{"entity":{"type":"insider","cik":"0001807359","url":"/insider/0001807359","json_url":"/insider/0001807359.json","name":"Epperly Melissa B,","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":52,"n_filings":19,"first":"2020-11-25","last":"2026-07-01","span_basis":"filed_date"},"name_variants":[{"name":"Epperly Melissa B,","source":"filing","n_filings":19,"first_seen":"2020-11-25","last_seen":"2026-07-01"}],"transactions":[{"id":5816479,"accession":"0001807359-26-000010","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001807359-26-000010","line_url":"/filing/0001807359-26-000010","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001807359","owner_name":"Epperly Melissa B,","owner_display_name":"Epperly Melissa B,","owner_url":"/insider/0001807359","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17750.0,"shares_display":"17,750","price_per_share":34.380378591549295,"price_display":"34.38","price_state":"stated","total_value":610251.72,"total_display":"610,251.72","total_whole":"610,252","shares_owned_after":19222.0,"shares_owned_after_display":"19,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-29","filed_date":"2026-07-01","scope":"insider","n_lines":2},{"id":5840992,"accession":"0001807359-26-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001807359-26-000004","line_url":"/filing/0001807359-26-000004#line-1","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001807359","owner_name":"Epperly Melissa B,","owner_display_name":"Epperly Melissa B,","owner_url":"/insider/0001807359","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41861.0,"shares_display":"41,861","price_per_share":28.68,"price_display":"28.68","price_state":"stated","total_value":1200573.48,"total_display":"1,200,573.48","total_whole":"1,200,573","shares_owned_after":15804.0,"shares_owned_after_display":"15,804","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-16","filed_date":"2026-03-18","scope":"insider"},{"id":2406764,"accession":"0001725160-24-000043","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001725160-24-000043","line_url":"/filing/0001725160-24-000043#line-1","is_derivative":false,"issuer_cik":"0001725160","issuer_name":"Zentalis Pharmaceuticals, Inc.","issuer_ticker":"ZNTL","issuer_name_source":null,"issuer_url":"/issuer/0001725160","owner_cik":"0001807359","owner_name":"Epperly Melissa B,","owner_display_name":"Epperly Melissa B,","owner_url":"/insider/0001807359","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2573.0,"shares_display":"2,573","price_per_share":11.44,"price_display":"11.44","price_state":"stated","total_value":29435.12,"total_display":"29,435.12","total_whole":"29,435","shares_owned_after":451449.0,"shares_owned_after_display":"451,449","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-12","filed_date":"2024-02-12","scope":"insider"},{"id":2924873,"accession":"0001725160-24-000028","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001725160-24-000028","line_url":"/filing/0001725160-24-000028#line-2","is_derivative":false,"issuer_cik":"0001725160","issuer_name":"Zentalis Pharmaceuticals, Inc.","issuer_ticker":"ZNTL","issuer_name_source":null,"issuer_url":"/issuer/0001725160","owner_cik":"0001807359","owner_name":"Epperly Melissa B,","owner_display_name":"Epperly Melissa B,","owner_url":"/insider/0001807359","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8669.0,"shares_display":"8,669","price_per_share":11.54,"price_display":"11.54","price_state":"stated","total_value":100040.26,"total_display":"100,040.26","total_whole":"100,040","shares_owned_after":454022.0,"shares_owned_after_display":"454,022","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-02","filed_date":"2024-02-05","scope":"insider"},{"id":8640811,"accession":"0001725160-23-000179","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001725160-23-000179","line_url":"/filing/0001725160-23-000179","is_derivative":false,"issuer_cik":"0001725160","issuer_name":"Zentalis Pharmaceuticals, Inc.","issuer_ticker":"ZNTL","issuer_name_source":null,"issuer_url":"/issuer/0001725160","owner_cik":"0001807359","owner_name":"Epperly Melissa B,","owner_display_name":"Epperly Melissa B,","owner_url":"/insider/0001807359","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5482.0,"shares_display":"5,482","price_per_share":19.504851988325427,"price_display":"19.50","price_state":"stated","total_value":106925.5986,"total_display":"106,925.60","total_whole":"106,926","shares_owned_after":388579.0,"shares_owned_after_display":"388,579","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-04","filed_date":"2023-10-06","scope":"insider","n_lines":2},{"id":8212250,"accession":"0001725160-23-000035","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001725160-23-000035","line_url":"/filing/0001725160-23-000035#line-2","is_derivative":false,"issuer_cik":"0001725160","issuer_name":"Zentalis Pharmaceuticals, Inc.","issuer_ticker":"ZNTL","issuer_name_source":null,"issuer_url":"/issuer/0001725160","owner_cik":"0001807359","owner_name":"Epperly Melissa B,","owner_display_name":"Epperly Melissa B,","owner_url":"/insider/0001807359","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5227.0,"shares_display":"5,227","price_per_share":19.9753,"price_display":"19.98","price_state":"stated","total_value":104410.8931,"total_display":"104,410.89","total_whole":"104,411","shares_owned_after":392048.0,"shares_owned_after_display":"392,048","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-14","filed_date":"2023-02-14","scope":"insider"},{"id":8212249,"accession":"0001725160-23-000035","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001725160-23-000035","line_url":"/filing/0001725160-23-000035#line-1","is_derivative":false,"issuer_cik":"0001725160","issuer_name":"Zentalis Pharmaceuticals, Inc.","issuer_ticker":"ZNTL","issuer_name_source":null,"issuer_url":"/issuer/0001725160","owner_cik":"0001807359","owner_name":"Epperly Melissa B,","owner_display_name":"Epperly Melissa B,","owner_url":"/insider/0001807359","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2624.0,"shares_display":"2,624","price_per_share":20.4244,"price_display":"20.42","price_state":"stated","total_value":53593.6256,"total_display":"53,593.63","total_whole":"53,594","shares_owned_after":397275.0,"shares_owned_after_display":"397,275","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-13","filed_date":"2023-02-14","scope":"insider"},{"id":6662406,"accession":"0001725160-22-000069","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001725160-22-000069","line_url":"/filing/0001725160-22-000069","is_derivative":false,"issuer_cik":"0001725160","issuer_name":"Zentalis Pharmaceuticals, Inc.","issuer_ticker":"ZNTL","issuer_name_source":null,"issuer_url":"/issuer/0001725160","owner_cik":"0001807359","owner_name":"Epperly Melissa B,","owner_display_name":"Epperly Melissa B,","owner_url":"/insider/0001807359","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17080.0,"shares_display":"17,080","price_per_share":50.0891349882904,"price_display":"50.09","price_state":"stated","total_value":855522.4256,"total_display":"855,522.43","total_whole":"855,522","shares_owned_after":256400.0,"shares_owned_after_display":"256,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-04","filed_date":"2022-04-05","scope":"insider","n_lines":5},{"id":6793817,"accession":"0001725160-22-000047","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001725160-22-000047","line_url":"/filing/0001725160-22-000047","is_derivative":false,"issuer_cik":"0001725160","issuer_name":"Zentalis Pharmaceuticals, Inc.","issuer_ticker":"ZNTL","issuer_name_source":null,"issuer_url":"/issuer/0001725160","owner_cik":"0001807359","owner_name":"Epperly Melissa B,","owner_display_name":"Epperly Melissa B,","owner_url":"/insider/0001807359","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1913.0,"shares_display":"1,913","price_per_share":49.096053998954524,"price_display":"49.10","price_state":"stated","total_value":93920.7513,"total_display":"93,920.75","total_whole":"93,921","shares_owned_after":265196.0,"shares_owned_after_display":"265,196","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-23","filed_date":"2022-02-23","scope":"insider","n_lines":2},{"id":4703306,"accession":"0001725160-21-000185","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001725160-21-000185","line_url":"/filing/0001725160-21-000185#line-2","is_derivative":false,"issuer_cik":"0001725160","issuer_name":"Zentalis Pharmaceuticals, Inc.","issuer_ticker":"ZNTL","issuer_name_source":null,"issuer_url":"/issuer/0001725160","owner_cik":"0001807359","owner_name":"Epperly Melissa B,","owner_display_name":"Epperly Melissa B,","owner_url":"/insider/0001807359","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8285.0,"shares_display":"8,285","price_per_share":51.9976,"price_display":"52.00","price_state":"stated","total_value":430800.116,"total_display":"430,800.12","total_whole":"430,800","shares_owned_after":266685.0,"shares_owned_after_display":"266,685","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-19","filed_date":"2021-08-20","scope":"insider"},{"id":4703304,"accession":"0001725160-21-000185","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001725160-21-000185","line_url":"/filing/0001725160-21-000185#line-1","is_derivative":false,"issuer_cik":"0001725160","issuer_name":"Zentalis Pharmaceuticals, Inc.","issuer_ticker":"ZNTL","issuer_name_source":null,"issuer_url":"/issuer/0001725160","owner_cik":"0001807359","owner_name":"Epperly Melissa B,","owner_display_name":"Epperly Melissa B,","owner_url":"/insider/0001807359","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1326.0,"shares_display":"1,326","price_per_share":51.997,"price_display":"52.00","price_state":"stated","total_value":68948.022,"total_display":"68,948.02","total_whole":"68,948","shares_owned_after":258400.0,"shares_owned_after_display":"258,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-18","filed_date":"2021-08-20","scope":"insider"},{"id":5506409,"accession":"0001725160-21-000163","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001725160-21-000163","line_url":"/filing/0001725160-21-000163","is_derivative":false,"issuer_cik":"0001725160","issuer_name":"Zentalis Pharmaceuticals, Inc.","issuer_ticker":"ZNTL","issuer_name_source":null,"issuer_url":"/issuer/0001725160","owner_cik":"0001807359","owner_name":"Epperly Melissa B,","owner_display_name":"Epperly Melissa B,","owner_url":"/insider/0001807359","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3083.0,"shares_display":"3,083","price_per_share":51.266405060006484,"price_display":"51.27","price_state":"stated","total_value":158054.3268,"total_display":"158,054.33","total_whole":"158,054","shares_owned_after":258079.0,"shares_owned_after_display":"258,079","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-01","filed_date":"2021-07-06","scope":"insider","n_lines":4},{"id":5231977,"accession":"0001725160-21-000135","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001725160-21-000135","line_url":"/filing/0001725160-21-000135","is_derivative":false,"issuer_cik":"0001725160","issuer_name":"Zentalis Pharmaceuticals, Inc.","issuer_ticker":"ZNTL","issuer_name_source":null,"issuer_url":"/issuer/0001725160","owner_cik":"0001807359","owner_name":"Epperly Melissa B,","owner_display_name":"Epperly Melissa B,","owner_url":"/insider/0001807359","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3083.0,"shares_display":"3,083","price_per_share":54.05155825494648,"price_display":"54.05","price_state":"stated","total_value":166640.9541,"total_display":"166,640.95","total_whole":"166,641","shares_owned_after":260357.0,"shares_owned_after_display":"260,357","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-01","filed_date":"2021-06-02","scope":"insider","n_lines":2},{"id":4492218,"accession":"0001725160-21-000120","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001725160-21-000120","line_url":"/filing/0001725160-21-000120","is_derivative":false,"issuer_cik":"0001725160","issuer_name":"Zentalis Pharmaceuticals, Inc.","issuer_ticker":"ZNTL","issuer_name_source":null,"issuer_url":"/issuer/0001725160","owner_cik":"0001807359","owner_name":"Epperly Melissa B,","owner_display_name":"Epperly Melissa B,","owner_url":"/insider/0001807359","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3083.0,"shares_display":"3,083","price_per_share":59.239290917937076,"price_display":"59.24","price_state":"stated","total_value":182634.7339,"total_display":"182,634.73","total_whole":"182,635","shares_owned_after":263240.0,"shares_owned_after_display":"263,240","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-03","filed_date":"2021-05-05","scope":"insider","n_lines":4},{"id":4285593,"accession":"0001725160-21-000090","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001725160-21-000090","line_url":"/filing/0001725160-21-000090","is_derivative":false,"issuer_cik":"0001725160","issuer_name":"Zentalis Pharmaceuticals, Inc.","issuer_ticker":"ZNTL","issuer_name_source":null,"issuer_url":"/issuer/0001725160","owner_cik":"0001807359","owner_name":"Epperly Melissa B,","owner_display_name":"Epperly Melissa B,","owner_url":"/insider/0001807359","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17107.0,"shares_display":"17,107","price_per_share":43.3929610276495,"price_display":"43.39","price_state":"stated","total_value":742323.3843,"total_display":"742,323.38","total_whole":"742,323","shares_owned_after":266555.0,"shares_owned_after_display":"266,555","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-05","filed_date":"2021-04-06","scope":"insider","n_lines":4},{"id":4703290,"accession":"0001725160-21-000050","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001725160-21-000050","line_url":"/filing/0001725160-21-000050#line-1","is_derivative":false,"issuer_cik":"0001725160","issuer_name":"Zentalis Pharmaceuticals, Inc.","issuer_ticker":"ZNTL","issuer_name_source":null,"issuer_url":"/issuer/0001725160","owner_cik":"0001807359","owner_name":"Epperly Melissa B,","owner_display_name":"Epperly Melissa B,","owner_url":"/insider/0001807359","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3083.0,"shares_display":"3,083","price_per_share":41.6745,"price_display":"41.67","price_state":"stated","total_value":128482.4835,"total_display":"128,482.48","total_whole":"128,482","shares_owned_after":283430.0,"shares_owned_after_display":"283,430","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-03","scope":"insider"},{"id":5474814,"accession":"0001725160-21-000022","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001725160-21-000022","line_url":"/filing/0001725160-21-000022","is_derivative":false,"issuer_cik":"0001725160","issuer_name":"Zentalis Pharmaceuticals, Inc.","issuer_ticker":"ZNTL","issuer_name_source":null,"issuer_url":"/issuer/0001725160","owner_cik":"0001807359","owner_name":"Epperly Melissa B,","owner_display_name":"Epperly Melissa B,","owner_url":"/insider/0001807359","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3083.0,"shares_display":"3,083","price_per_share":37.56233327927343,"price_display":"37.56","price_state":"stated","total_value":115804.6735,"total_display":"115,804.67","total_whole":"115,805","shares_owned_after":271896.0,"shares_owned_after_display":"271,896","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-01","filed_date":"2021-02-03","scope":"insider","n_lines":2},{"id":5534347,"accession":"0001725160-21-000005","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001725160-21-000005","line_url":"/filing/0001725160-21-000005","is_derivative":false,"issuer_cik":"0001725160","issuer_name":"Zentalis Pharmaceuticals, Inc.","issuer_ticker":"ZNTL","issuer_name_source":null,"issuer_url":"/issuer/0001725160","owner_cik":"0001807359","owner_name":"Epperly Melissa B,","owner_display_name":"Epperly Melissa B,","owner_url":"/insider/0001807359","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3083.0,"shares_display":"3,083","price_per_share":51.908468083036006,"price_display":"51.91","price_state":"stated","total_value":160033.8071,"total_display":"160,033.81","total_whole":"160,034","shares_owned_after":274696.0,"shares_owned_after_display":"274,696","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-04","filed_date":"2021-01-06","scope":"insider","n_lines":4},{"id":3202344,"accession":"0001725160-20-000059","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001725160-20-000059","line_url":"/filing/0001725160-20-000059","is_derivative":false,"issuer_cik":"0001725160","issuer_name":"Zentalis Pharmaceuticals, Inc.","issuer_ticker":"ZNTL","issuer_name_source":null,"issuer_url":"/issuer/0001725160","owner_cik":"0001807359","owner_name":"Epperly Melissa B,","owner_display_name":"Epperly Melissa B,","owner_url":"/insider/0001807359","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6464.0,"shares_display":"6,464","price_per_share":53.521541754331686,"price_display":"53.52","price_state":"stated","total_value":345963.2459,"total_display":"345,963.25","total_whole":"345,963","shares_owned_after":278070.0,"shares_owned_after_display":"278,070","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-07","filed_date":"2020-12-08","scope":"insider","n_lines":4},{"id":3202332,"accession":"0001725160-20-000059","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001725160-20-000059","line_url":"/filing/0001725160-20-000059","is_derivative":false,"issuer_cik":"0001725160","issuer_name":"Zentalis Pharmaceuticals, Inc.","issuer_ticker":"ZNTL","issuer_name_source":null,"issuer_url":"/issuer/0001725160","owner_cik":"0001807359","owner_name":"Epperly Melissa B,","owner_display_name":"Epperly Melissa B,","owner_url":"/insider/0001807359","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7220.0,"shares_display":"7,220","price_per_share":50.98291574792244,"price_display":"50.98","price_state":"stated","total_value":368096.6517,"total_display":"368,096.65","total_whole":"368,097","shares_owned_after":284143.0,"shares_owned_after_display":"284,143","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-04","filed_date":"2020-12-08","scope":"insider","n_lines":2},{"id":2160461,"accession":"0001725160-20-000048","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001725160-20-000048","line_url":"/filing/0001725160-20-000048","is_derivative":false,"issuer_cik":"0001725160","issuer_name":"Zentalis Pharmaceuticals, Inc.","issuer_ticker":"ZNTL","issuer_name_source":null,"issuer_url":"/issuer/0001725160","owner_cik":"0001807359","owner_name":"Epperly Melissa B,","owner_display_name":"Epperly Melissa B,","owner_url":"/insider/0001807359","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3083.0,"shares_display":"3,083","price_per_share":51.46959951346091,"price_display":"51.47","price_state":"stated","total_value":158680.7753,"total_display":"158,680.78","total_whole":"158,681","shares_owned_after":292221.0,"shares_owned_after_display":"292,221","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-02","filed_date":"2020-12-03","scope":"insider","n_lines":4},{"id":3016237,"accession":"0001725160-20-000042","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001725160-20-000042","line_url":"/filing/0001725160-20-000042#line-3","is_derivative":false,"issuer_cik":"0001725160","issuer_name":"Zentalis Pharmaceuticals, Inc.","issuer_ticker":"ZNTL","issuer_name_source":null,"issuer_url":"/issuer/0001725160","owner_cik":"0001807359","owner_name":"Epperly Melissa B,","owner_display_name":"Epperly Melissa B,","owner_url":"/insider/0001807359","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2783.0,"shares_display":"2,783","price_per_share":46.5097,"price_display":"46.51","price_state":"stated","total_value":129436.4951,"total_display":"129,436.50","total_whole":"129,436","shares_owned_after":294746.0,"shares_owned_after_display":"294,746","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-23","filed_date":"2020-11-25","scope":"insider"}],"collapsed":true,"next_cursor":"2020-11-23|3016237","ledger_fault":false,"count":{"value":52,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":49,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":52},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001635088","name":"Roivant Sciences Ltd.","url":"/issuer/0001635088","role":"Director","n_filings":2,"first_seen":"2026-03-18","last_seen":"2026-07-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001725160","name":"Zentalis Pharmaceuticals, Inc.","url":"/issuer/0001725160","role":"Officer (Chief Financial Officer)","n_filings":17,"first_seen":"2020-11-25","last_seen":"2024-02-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001807359","retrieved_at":"2026-08-22T21:24:09+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}